| 生物医药产业专利技术融入标准现状分析与对策研究 |
| |
| 引用本文： | 韩晓东,王文兰,刘岩峰. 生物医药产业专利技术融入标准现状分析与对策研究[J]. 世界标准化与质量管理, 2011, 0(2): 32-35 |
| |
| 作者姓名： | 韩晓东 王文兰 刘岩峰 |
| |
| 作者单位： | 吉林省标准研究院,吉林,长春,130022 |
| |
| 基金项目： | "十一五"国家科技支撑计划重点专项 |
| |
| 摘 要： | 文章从专利与药品标准的关系出发，进行了生物医药产业专利融入药品质量标准的现状研究和问题分析，提出了专利技术纳入药品国家标准的条件，并分别从政府和企业两个层面给出了加快生物医药产业自主创新技术融入标准的可行性建议。
|
| 关 键 词： | 专利技术 生物医药 药品国家标准 |
Status Analysis and Countermeasures Study on Patent Technology Introduced into National Drug Standards of Biological Medicine Industry |
| |
| HAN Xiao-dong,WANG Wen-lan,LIU Yan-feng. Status Analysis and Countermeasures Study on Patent Technology Introduced into National Drug Standards of Biological Medicine Industry[J]. World Standardization & Quality Management, 2011, 0(2): 32-35 |
| |
| Authors: | HAN Xiao-dong WANG Wen-lan LIU Yan-feng |
| |
| Affiliation: | ( Standards Institute of Jilin Province, Changchun 130022, China) |
| |
| Abstract: | Based on the relationship between patent and drug standards, this paper systematically discusses the status and the current weakness of patent technology introduced into drug standards of biological medicine industry, puts forward some feasible conditions, and gives some countermeasures on promoting the patent technology introduced into national drug standards of biological medicine industry both in government and in enterprises of China. |
| |
| Keywords: | patent technology biological medicine industry national drug standards |
| 本文献已被 维普 万方数据 等数据库收录！ |
|
